Artiva Biotherapeutics, Inc. ARTV
- AB-201 — Breast Cancer
- AB-201 — Gastric Cancer
- AB-201 — Bladder Cancer
HER2 (5 companies · 9 programs)
Companies with an active program directed at HER2.
Cogent Biosciences, Inc. COGT
- CGT4255 Phase 1
- CGT4255 Phase 1
Vir Biotechnology, Inc. VIR
- VIR-5818 — Breast Cancer Phase 1
- VIR-5818 — Colorectal Cancer Phase 1
Absci Corporation ABSI
- ABS-501 Preclinical
Adagene Inc. ADAG
- ADG138 Preclinical